Spineguard Stock EBITDA

ALSGD Stock  EUR 0.23  0.01  4.55%   
Spineguard fundamentals help investors to digest information that contributes to Spineguard's financial success or failures. It also enables traders to predict the movement of Spineguard Stock. The fundamental analysis module provides a way to measure Spineguard's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Spineguard stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Spineguard Company EBITDA Analysis

Spineguard's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Spineguard EBITDA

    
  (812.46 K)  
Most of Spineguard's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spineguard is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Spineguard reported earnings before interest,tax, depreciation and amortization of (812,463). This is 100.09% lower than that of the Health Care Equipment & Supplies sector and 100.13% lower than that of the Health Care industry. The ebitda for all France stocks is 100.02% higher than that of the company.

Spineguard EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spineguard's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Spineguard could also be used in its relative valuation, which is a method of valuing Spineguard by comparing valuation metrics of similar companies.
Spineguard is currently under evaluation in ebitda category among its peers.

Spineguard Fundamentals

About Spineguard Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Spineguard's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spineguard using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spineguard based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Spineguard Stock Analysis

When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.